Publications by authors named "Dale Usner"

Claim this Profile
A
Administration of the Travoprost Intracameral Implant in an Office-Based Surgery Setting.
Inder Paul Singh, George R Reiss, Brian E Flowers, L Jay Katz, Dale W Usner

Ophthalmol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aqueous Humor Concentrations of Travoprost Free Acid and Residual Drug in Explanted Implants from Patients Administered a Travoprost Intracameral Implant.
Gabriella Szekely, Lilit A Voskanyan, Kerry G Stephens, Long V Doan, Jennifer R Seal, Dale W Usner

Ophthalmol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of travoprost intracameral implant administered in combination with cataract surgery.
Inder Paul Singh, Lilit A Voskanyan, Kevin M Barber, James H Burden, LeAnne Connolly, Dale W Usner

Ther Adv Ophthalmol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension.
Steven R Sarkisian, Robert E Ang, Andy M Lee, John P Berdahl, Sebastian B Heersink, Dale W Usner

Ophthalmology· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension.
Jason Bacharach, Long V Doan, Kerry G Stephens, Dale W Usner, Angela C Kothe

Ophthalmol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension: 12-Month Results of a Randomized, Double-Masked Trial.
Steven R Sarkisian, Robert E Ang, Andy M Lee, John P Berdahl, Sebastian B Heersink, Dale W Usner

Ophthalmol Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension.
John P Berdahl, Steven R Sarkisian, Robert E Ang, Long V Doan, Angela C Kothe, Dale W Usner

Drugs· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Endothelial Safety Profile With iStent Inject in Patients With Open-Angle Glaucoma.
Iqbal Ike K Ahmed, Arsham Sheybani, Ticiana De Francesco, Jonathan H Lass, Beth Ann Benetz, Dale Usner

Am J Ophthalmol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OCS-01 (Novel Topical Dexamethasone Formulation) in Inflammation and Pain Post Cataract Surgery: A Randomized, Double-Masked, Vehicle-Controlled Study.
Michael Korenfeld, Joe Gira, Kevin Jong, Joseph Martel, Steven Vold, Dale Usner

Clin Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study.
Thomas R Walters, Angela C Kothe, José L Boyer, Dale W Usner, Krisol Lopez

J Glaucoma· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study.
John D Sheppard, David L Wirta, Eugene McLaurin, Blair E Boehmer, Joseph B Ciolino, Dale Usner

Cornea· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One Year of Netarsudil and Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Phase 3, Randomized MERCURY-1 Study.
Jacob W Brubaker, Savak Teymoorian, Richard A Lewis, Dale Usner, Hayley J McKee

Ophthalmol Glaucoma· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Daily Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure in the Randomized Phase 3 MERCURY-2 Study.
Thomas R Walters, Iqbal Ike K Ahmed, Richard A Lewis, Dale W Usner, Jae Lopez

Ophthalmol Glaucoma· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension.
Inder P Singh, Robert D Fechtner, Jonathan S Myers, Terry Kim, Dale W Usner

J Glaucoma· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial.
Sanjay Asrani, Alan L Robin, Janet B Serle, Richard A Lewis, Dale W Usner

Am J Ophthalmol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study.
Albert S Khouri, Janet B Serle, Jason Bacharach, Dale W Usner, Richard A Lewis

Am J Ophthalmol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2).
Malik Y Kahook, Janet B Serle, Francis S Mah, Terry Kim, Michael B Raizman, Dale W Usner

Am J Ophthalmol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Janet B Serle, L Jay Katz, Eugene McLaurin, Theresa Heah, Nancy Ramirez-Davis, Dale W Usner

Am J Ophthalmol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension.
Richard A Lewis, Brian Levy, Nancy Ramirez, Casey C Kopczynski, Dale W Usner

Br J Ophthalmol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza.
Eleanor L Ramos, Jennifer L Mitcham, Teri D Koller, Aurelio Bonavia, Dale W Usner

J Infect Dis· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant.
John D Sheppard, Quan Dong Nguyen, Dale W Usner, Timothy L Comstock

Clin Ophthalmol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes.
Timothy W Morris, Lynne S Gearinger, Dale W Usner, Michael R Paterno, Heleen H Decory

Clin Ophthalmol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile.
Wolfgang Haas, Lynne S Gearinger, Dale W Usner, Heleen H Decory, Timothy W Morris

Clin Ophthalmol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis: data from six clinical and phase I safety studies.
Timothy L Comstock, Michael R Paterno, Heleen H Decory, Dale W Usner

Clin Drug Investig· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
Timothy L Comstock, Michael R Paterno, Dale W Usner, Michael E Pichichero

Paediatr Drugs· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis